Fact-checked by Grok 2 weeks ago

Cochrane Library

The Cochrane Library is a comprehensive collection of online databases that provide high-quality, independent evidence to support healthcare decision-making, featuring systematic reviews, clinical trials data, and other resources focused on health interventions and policies. Established in 1993 by the Cochrane Collaboration—a global, independent, non-profit network of researchers, professionals, patients, and caregivers—the Library was founded in , , to facilitate the preparation and dissemination of systematic reviews of randomized controlled trials in healthcare. Named after the British epidemiologist Archibald Cochrane (1909–1988), who pioneered the concept of by advocating for the assembly of reliable summaries of all relevant randomized trials, the Library has evolved into a cornerstone of evidence-informed practice. Today, it operates under the broader Cochrane organization, which includes contributors worldwide, with members and supporters from over 190 countries as of 2025, working collaboratively to produce and update evidence. The Library's core components include the Cochrane Database of Systematic Reviews (CDSR), the leading peer-reviewed journal for systematic reviews covering topics across healthcare and ; the Cochrane Central Register of Controlled Trials (CENTRAL), a database of randomized and quasi-randomized controlled trials sourced from sources like , , and ; and Cochrane Clinical Answers, which distills evidence from CDSR into concise, clinically relevant responses to common questions. Additional features encompass protocols for ongoing reviews, editorials, special collections on priority topics, and tools like search for structured querying based on , , , and outcomes. All content undergoes rigorous and methodological standards to ensure reliability, with reviews updated regularly to reflect new evidence. Access to the Cochrane Library is available through subscriptions for institutions and individuals, though free access is provided in many low- and middle-income countries via national or regional licenses, promoting equitable use by healthcare professionals, policymakers, patients, and the public. Its evidence has significantly influenced global health practices, from treatment guidelines for conditions like and malaria to policy decisions on interventions, underscoring its role in advancing better health outcomes.

Overview

Purpose and Scope

The Cochrane Library is a collection of databases that contain high-quality, independent evidence to inform healthcare decision-making, including systematic reviews of randomized controlled trials (RCTs) and other rigorous research. Its core mission is to produce reliable health evidence that supports informed decisions by health professionals, patients, and policymakers, thereby contributing to better health outcomes globally. The scope of the Cochrane Library encompasses a broad range of topics across all healthcare specialties, including interventions, diagnostic tests, services, and issues. It emphasizes minimizing through standardized, objective methodologies in systematic reviews, ensuring the evidence is trustworthy and relevant to pressing challenges in diverse cultural and global settings. This coverage extends to any topic relevant to healthcare, facilitating evidence-based approaches to clinical practice and . Guided by key principles of , , and global accessibility, the Cochrane Library maintains rigorous editorial policies and involves diverse contributors such as researchers, clinicians, and patients to uphold trust in its outputs. It provides summaries and translations in over 20 languages to enhance usability for non-experts and support access in low- and middle-income countries. Published by Wiley with 1465-1858, the resource is accessible via cochranelibrary.com. Founded by the Cochrane Collaboration, it continues to evolve as a cornerstone of .

History

The Cochrane Library traces its roots to the work of Archibald (Archie) Cochrane (1909–1988), a Scottish epidemiologist who pioneered the concept of evidence-based medicine. In his 1972 book Effectiveness and Efficiency: Random Reflections on Health Services, Cochrane advocated for the systematic review of randomized controlled trials (RCTs) to assess healthcare interventions, highlighting the need for reliable evidence to inform medical decisions. The Cochrane Collaboration was formally established in October 1993 in , , under the leadership of Iain Chalmers and a group of international researchers, with the aim of facilitating the preparation and maintenance of high-quality systematic reviews of RCTs in healthcare. That same year, the first Cochrane Review Groups were created to coordinate the production of these reviews across specific health topics, marking the beginning of a decentralized, volunteer-driven network. The Cochrane Library was launched in 1995 as the world's first digital-only publication dedicated to systematic reviews, with the inaugural issue of the Cochrane Database of Systematic Reviews (CDSR) appearing in April and distributed initially on . By the late , the Library had expanded to incorporate additional databases, such as the Database of Abstracts of Reviews of Effects () and the Cochrane Central Register of Controlled Trials (CENTRAL), reflecting growing collaboration among over 1,000 contributors worldwide. In 2003, the partnership with John Wiley & Sons Ltd. began, succeeding Update Software as the publisher and enabling broader online dissemination. Over the subsequent decades, the initiative evolved from a modest, volunteer-led effort into a global network involving thousands of researchers, healthcare professionals, and patients across more than 190 countries. In 2025, key advancements included the transition to for all protocols and editorials in the CDSR, enhancing accessibility for global users, alongside the formation of a new Methods Group in collaboration with organizations like the Campbell Collaboration and to integrate responsibly into evidence synthesis processes. The Cochrane Methods Report 2025 further documented these methodological innovations, emphasizing diverse evidence synthesis approaches to address evolving priorities.

Organization and Governance

Structure of Cochrane

Cochrane operates as a global, independent, non-profit network comprising 158,000 members and supporters from over 200 countries and territories, encompassing researchers, health professionals, patients, and carers who collaborate to produce high-quality evidence syntheses. This decentralized structure emphasizes volunteer contributions and international cooperation, with the organization registered as a charity and company to facilitate coordination without commercial influence. At its core, Cochrane's operational framework includes a Central Executive Team based in , which provides strategic leadership and oversees global coordination across all activities. The network features Review Groups organized into eight Networks, each specializing in specific health topics such as , cancer, or infectious diseases, responsible for commissioning, developing, and maintaining systematic reviews within their domains, though several groups closed in 2023 following the cessation of core funding from the UK's National Institute for Health and Care Research (NIHR) effective March 31, 2023. These groups are supported by Geographic Groups in more than 50 countries, which offer logistical assistance, training, and promotion of Cochrane resources tailored to local contexts. Editorial processes within this structure enforce rigorous standards, including by experts and adherence to methodological guidelines to ensure transparency and reliability in all outputs. The production workflow begins with authors—often teams from Review Groups—submitting detailed protocols outlining planned review methods, which undergo editorial approval before full execution. Reviews are then conducted using standardized approaches, such as the Methodological Expectations of Cochrane Intervention Reviews (MECIR) for conduct and for reporting, to minimize bias and enhance reproducibility. Completed reviews and their updates are integrated into the Cochrane Database of Systematic Reviews (CDSR), with regular revisions—typically annually or more frequently for living reviews—to reflect emerging evidence, published in monthly issues. Technology plays an integral role in streamlining operations, with tools like Covidence serving as the primary platform for collaborative screening, data extraction, and review management, used in approximately 78% of Cochrane reviews. In 2025, Cochrane has advanced the integration of for tasks such as title and abstract screening to accelerate evidence synthesis while maintaining human oversight for accuracy and ethical considerations, including the formation of a new AI Methods Group.

Funding and Sustainability

The primary funding for Cochrane's central functions derives from royalties generated through subscriptions to the Cochrane Library, published exclusively by John Wiley & Sons since 2003 following a transition from Update Software. These royalties, amounting to approximately £7.5 million (as of the year ended December 2024), form the largest revenue stream and support core operations including evidence production and methods development. Supplementary funding comes from diverse sources such as governmental bodies, supranational organizations like the , non-governmental organizations, academic institutions, hospitals, and philanthropic grants, which collectively contribute through targeted support for specific initiatives and review groups. National-level provisions significantly bolster revenue stability, with many countries securing nationwide access agreements that cover substantial portions of subscriptions. For instance, the UK's National Institute for Health and Care Excellence funds free access for all residents of via the , while the Australian government provides similar nationwide funding to ensure broad availability. These agreements, often negotiated directly with Wiley, not only generate reliable income but also align with priorities by promoting equitable evidence dissemination. To enhance long-term viability, Cochrane has pursued sustainability initiatives including a shift to hybrid models and diversification beyond traditional subscriptions. In April 2024, Cochrane outlined a roadmap committing to full for all review protocols and editorials starting in 2025, building on existing policies where reviews become freely accessible after 12 months. Complementary efforts involve expanding revenue through training programs like Cochrane , partnerships for specialized products such as RevMan software, and rapid response services, which together generated over £2 million in the recent . Key challenges center on balancing aspirations for unrestricted open access with the high costs of producing and maintaining systematic reviews, estimated in the millions annually for central functions alone, exacerbated by the 2023 NIHR funding cut. Total charitable expenditures reached £10.6 million in 2024, with evidence production accounting for a significant share, necessitating ongoing strategies like a £3 million Continuity Fund to mitigate financial pressures during transitions. These efforts aim to reduce dependency on subscription royalties while preserving the independence and quality of Cochrane's .

Contents

The Cochrane Database of Systematic Reviews

The Cochrane Database of Systematic Reviews (CDSR) serves as the flagship component of the Cochrane Library, comprising full-text, peer-reviewed systematic reviews, protocols outlining pre-planned reviews, and editorials focused on healthcare interventions across diverse medical domains. These materials are produced by Cochrane's global network of review groups, ensuring rigorous, evidence-based synthesis to inform and policy. As of November 2025, the CDSR contains 9,510 published systematic reviews and 2,308 protocols, reflecting continuous growth in evidence synthesis. Content is organized into monthly issues, covering topics from and to specialized fields like and , with new and updated reviews added regularly to maintain relevance. Each systematic review follows a standardized structure to enhance and , beginning with a plain language summary that distills key findings for non-experts in accessible terms. The methods section details search strategies across databases, inclusion criteria, and risk of bias assessments using tools like RoB 2, while the results incorporate meta-analyses visualized through forest plots and certainty ratings via the , categorizing evidence as high, moderate, low, or very low. Implications for practice and policy conclude the review, highlighting actionable insights from the synthesized evidence. The CDSR is extensively abstracted and indexed in major databases, including /, , and , facilitating broad discoverability for researchers and clinicians. Impact is measured through journal-level metrics such as , which evaluates citation influence, alongside article-level indicators like tracking online attention and download statistics to gauge real-world engagement. In addition to core content, the CDSR features annual supplements addressing emerging topics, methodological advancements, and specialized syntheses, such as those on or living reviews. An academic allows for peer critiques and responses to published reviews, promoting ongoing and refinement within the evidence base.

Other Databases

In addition to the Cochrane Database of Systematic Reviews (CDSR), the Cochrane Library includes several supporting databases that provide essential resources for evidence synthesis and clinical decision-making. The Cochrane Central Register of Controlled Trials (CENTRAL) serves as a comprehensive database containing bibliographic reports of randomized controlled trials (RCTs) from trusted sources such as (via ), , and other specialized registers. As of the October 2025 update, CENTRAL holds over 2.31 million records, with monthly additions to ensure currency; for instance, this build incorporated new trial reports identified through ongoing searches. CENTRAL plays a critical role in the production of CDSR reviews by facilitating the identification and inclusion of relevant trials during processes. Cochrane Clinical Answers (CCAs) offer clinician-friendly summaries that distill key findings from CDSR reviews into concise question-and- formats, focusing on the most relevant outcomes for practice. Each CCA includes a clinical question, a short evidence-based , and graphical from the underlying review, making complex evidence accessible at the point of care. By mid-2025, the collection exceeded 3,500 CCAs, with enhancements such as Clinical Interpretations—succinct statements from practicing clinicians—to further aid interpretation. The Cochrane Library also features Special Collections, curated groupings of reviews and resources on specific topics, such as studies, to address timely health priorities; as of late 2025, there are 23 such collections. Historically, the Library included the Cochrane Methodology Register, a of methodological studies for trials that has since been integrated into broader Cochrane resources and is no longer separately updated. Similarly, the Health Technology Assessment database, which provided international reports on health technologies, was phased out after 2015, with no new records added thereafter. These auxiliary databases collectively enhance the Library's utility by supporting trial discovery, quick-reference tools, and focused evidence aggregation.

Access and Usage

Subscription and Open Access Models

The Cochrane Library primarily operates on a subscription-based model, where access is provided through institutional licenses to universities, hospitals, libraries, and other organizations, as well as individual subscriptions for personal use. These paid subscriptions grant full access to premium content, including the complete text of Cochrane Reviews, and are managed by publisher Wiley on behalf of Cochrane. Additionally, national licenses funded by governments enable free access for all residents in 14 countries, including members such as the , , , , , and , as well as non- nations like , , and ; for example, provides nationwide free access via a national license agreement. Complementing subscriptions, the Library offers progressive open access options to broaden accessibility. All Cochrane Reviews become freely available after a 12-month embargo period under a green model, while authors or their institutions can opt for immediate gold by paying an (APC) of $5,100 USD for a full review or update, enabling publication under a . Starting in 2025, all protocols and editorials will be fully upon publication without embargo or APC requirements, marking a step toward greater in . Free access to abstracts, plain language summaries, and selected other content is available to all users worldwide, regardless of subscription status. The platform is hosted at cochranelibrary.com, featuring advanced search functionalities such as (Population, Intervention, Comparison, Outcome) frameworks and (Medical Subject Headings) indexing to facilitate precise evidence retrieval. A dedicated is available for and devices, providing free access to abridged versions of systematic reviews and other core content in an easy-to-navigate format. Trial access periods are offered to institutions and new users to evaluate full content before committing to a subscription. Special provisions enhance equity for underserved regions: residents of over 100 low- and middle-income countries, as defined by the , receive free one-click access to the full Library through initiatives like HINARI (Health InterNetwork Access to Research Initiative) in partnership with the , supported by IP address recognition without requiring individual registration.

User Statistics and Reach

The Cochrane Library experiences substantial global usage, with over 125 million full-text reads of Cochrane reviews recorded in the past decade (as of 2024), averaging more than 12 million annually. The Cochrane Database of Systematic Reviews (CDSR) alone accounts for 13.6 million full-text article views in recent years, underscoring its role as a primary resource for evidence synthesis. Additionally, CDSR content has accumulated 83,897 citations (as of 2024), highlighting its integration into broader scholarly discourse, though cumulative citations for all Cochrane reviews exceed 1 million across thousands of publications. Access to the Cochrane Library extends to more than 200 countries and territories, facilitated by a network of over 158,000 members and supporters worldwide. Usage is highest in and , where national licensing agreements enable broad institutional and public access, while adoption is expanding in low- and middle-income regions through targeted free access initiatives covering over 100 countries. These programs, including one-click IP-based access, have particularly boosted reach in areas with limited resources, with nearly half of Cochrane's volunteer translators originating from such settings. In 2025, usage trends reflect sustained growth following health crises, including a marked increase in searches during and after the , where visits to the platform surged significantly before stabilizing at elevated levels. This period saw over 70 dedicated COVID-19 resources published, driving higher engagement with topics like and health worker support, with ongoing demand in 2025 for on emerging challenges. Article-level metrics further illustrate this, with individual Cochrane reviews averaging thousands of views and accumulating social shares that amplify dissemination beyond traditional academic channels. User demographics, drawn from platform analytics, indicate that the audience is predominantly clinicians (approximately 40%), followed by researchers (30%), policymakers (15%), and patients or the public (15%), reflecting the Library's design to support diverse stakeholders in evidence-based . Subscription and models have enabled this broad user base by ensuring equitable availability across professional and personal contexts.

Impact and Reception

Influence on Evidence-Based Medicine

The Cochrane Library has established itself as a cornerstone of by providing high-quality systematic reviews that are frequently cited in authoritative clinical guidelines worldwide. For instance, two-thirds of new World Health Organization (WHO) guidelines issued in the past five years reference at least one Cochrane review, underscoring its role in shaping global health recommendations. Similarly, the UK's National Institute for Health and Care Excellence () extensively incorporates Cochrane reviews into its clinical guidelines, with 731 citations across 106 guidelines analyzed up to 2011, demonstrating consistent reliance on this resource for synthesis. A notable example of its practical influence is the 2014 Cochrane review on neuraminidase inhibitors like (Tamiflu), which re-evaluated clinical trial data and questioned the drug's benefits for reducing complications, prompting regulatory bodies and governments to reassess stockpiling and usage policies. Beyond informing guidelines, the Cochrane Library stimulates further research by systematically identifying gaps in the existing evidence base, which has inspired the design and initiation of new clinical trials to address these deficiencies. By highlighting areas where evidence is insufficient or inconsistent, Cochrane reviews encourage researchers to prioritize understudied questions, thereby advancing the scientific agenda in . This process has been integrated into globally, with institutions like in incorporating Cochrane tools and training materials to teach students how to critically appraise and apply systematic reviews, fostering a new generation of evidence-literate clinicians. In policy-making, the Cochrane Library supports governmental health technology assessments (HTAs) by offering rigorous syntheses that inform decisions on and intervention adoption. Organizations such as and international HTA agencies draw on Cochrane's Database and systematic reviews to evaluate the clinical and economic value of healthcare technologies. As of 2025, Cochrane's methods reports have contributed to policy discussions on in healthcare, including frameworks for and in AI-assisted synthesis, helping governments navigate emerging technologies responsibly. The library's broader contributions include the widespread promotion of the (Grading of Recommendations , Development and Evaluation) system, which Cochrane has adopted as its standard for assessing the certainty of in systematic reviews, enabling more transparent and consistent judgments across health domains. Additionally, through initiatives like the Cochrane Equity Methods Group, it prioritizes understudied topics to advance , such as by guiding reviews to consider the of effects across populations and integrating lenses into processes.

Criticisms and Controversies

The Cochrane Library has faced criticism for the timeliness of its systematic reviews, with the average completion time from protocol to publication estimated at around 2 years, which can delay the dissemination of during rapidly evolving crises. For instance, during the , delays in updating living systematic reviews were attributed to editorial bottlenecks, funding losses, and waning author commitment, resulting in half of 25 COVID-19-focused reviews not being updated by mid-2023 and only four had been updated. This lag has been highlighted as a barrier to evidence synthesis, particularly when compared to non-Cochrane reviews that often complete faster due to less rigorous processes. Concerns over potential biases in Cochrane reviews have also emerged, notably in search strategies where approximately 10% of recent intervention reviews incorporated specific outcomes into their literature searches, risking by prioritizing studies aligned with predefined results rather than comprehensively capturing the evidence base. To address risks from unreliable , Cochrane introduced a in for managing potentially problematic studies, including those formally retracted or expressing serious concerns, such as retracted clinical trials; this guidance directs authors to assess and mitigate the impact of such studies on review conclusions, with examples including exclusions or sensitivity analyses for flawed trials. Major controversies have underscored internal tensions within Cochrane. In 2018, following a formal complaint about the review on exercise therapy for chronic fatigue syndrome (now termed , or ME/CFS), which recommended the therapy despite patient reports of harm, the review was temporarily withdrawn for revisions amid accusations of methodological flaws and insensitivity to patient perspectives. Additionally, debates over industry funding influences intensified that year when co-founder Gøtzsche was expelled from Cochrane's governing board after criticizing perceived pharma ties and calling for stricter conflict-of-interest rules, sparking a broader that led to resignations from several review groups and questions about the organization's independence despite its stated policies against industry sway in review production. In response to these challenges, Cochrane has implemented reforms emphasizing research integrity, particularly in 2025, positioning systematic reviewers as key players in detecting and excluding untrustworthy studies to uphold quality. Enhancements include greater transparency in methods, such as public declarations of interest in Cochrane Clinical Answers and updated guidance on assessment. There are also growing calls for accelerating updates through AI-enabled tools, which could automate screening and synthesis to reduce timelines from years to days while maintaining rigor, as demonstrated in pilot reproductions of Cochrane reviews.

References

  1. [1]
    Cochrane Library: Cochrane reviews
    The Cochrane Library is a collection of high-quality, independent evidence to inform healthcare decision-making, including the Cochrane Database of ...
  2. [2]
    Our story - Cochrane
    Cochrane was established in 1993 in Oxford, UK, 'to facilitate the preparation of systematic reviews of randomized controlled trials of health care.'.
  3. [3]
    Archibald Cochrane (1909–1988): the father of evidence-based ...
    Oct 18, 2013 · Professor Archibald Cochrane (1909–1988) is considered to be the originator of the idea of evidence-based medicine in our era.
  4. [4]
    About us - Cochrane
    Cochrane is a global, independent, non-profit network of health researchers and professionals, patients and carers who work together to produce and promote ...Our story · Who we are · News · Our groups<|control11|><|separator|>
  5. [5]
    About the Cochrane Database of Systematic Reviews
    The Cochrane Database of Systematic Reviews (CDSR) is the leading database for systematic reviews in health care.
  6. [6]
    How CENTRAL is created - Cochrane Library
    The Cochrane Central Register of Controlled Trials (CENTRAL) contains randomized controlled trial (RCT) and quasi-RCT (q-RCT) records.
  7. [7]
    Cochrane PICO search
    Cochrane PICO search is a tool to find Cochrane Reviews using PICO terms (Population, Intervention, Comparison, Outcome) to find relevant reviews.<|separator|>
  8. [8]
    Cochrane Database of Systematic Reviews: editorial policies
    The CDSR is a peer-reviewed publication, which means that all research articles are evaluated by one or more specialists before publication, and the authors ...
  9. [9]
    Cochrane Library access options
    Access to the Cochrane Library is available for free to all residents of Nova Scotia thanks to funding provided by the partnership involving Dalhousie ...
  10. [10]
    Our impact - Cochrane
    Cochrane has been improving people's lives and global health for more than 30 years. Our unique network of researchers, health professionals, patients and ...<|control11|><|separator|>
  11. [11]
    About the Cochrane Library
    The Cochrane Library is a collection of databases that contain different types of high-quality, independent evidence to inform healthcare decision-making.About The Cochrane Library · Databases · Cochrane Database Of...
  12. [12]
    What we do - Cochrane
    We write Cochrane reviews so that health professionals, patients and policymakers can all get accurate, trustworthy information when they need to make decisions ...
  13. [13]
    COCHRANE METHODS
    Sep 7, 2010 · The purpose of the Methods Board is to provide a broad forum for discus- sion and formulation of recommenda- tions on methods for Cochrane ...
  14. [14]
    Celebrating Archie Cochrane
    Jan 9, 2023 · Cochrane is named in honour of Archie Cochrane, a British medical researcher who contributed greatly to the development of epidemiology as a science.
  15. [15]
    Effectiveness and Efficiency: Random Reflections on Health Services
    In this seminal book, first published in 1972 by the Nuffield Provincial Hospitals Trust and issued in this imprint in 1999, he called for an international ...
  16. [16]
    The Cochrane Collaboration 20 years in - PMC - PubMed Central
    In 1993, evidence-informed health care was in its infancy. The term “evidence-based medicine” had recently been coined at McMaster University, the Institute ...
  17. [17]
    The origins, evolution, and future of The Cochrane Database of ...
    Jul 1, 2009 · The Cochrane Database of Systematic Reviews (CDSR) evolved in response to Archie Cochrane's challenge to the medical profession to assemble a critical summary.
  18. [18]
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10846358/
  19. [19]
    Changes to The Cochrane Library during The ... - PubMed Central
    A year after, in April 1996, The Cochrane Library was launched as a quarterly publication on CD‐ROM and floppy disk and incorporated the CDSR, the Cochrane ...
  20. [20]
    Celebrating 30 years of Cochrane
    Aug 28, 2023 · Cochrane, a global independent network of researchers, professionals, patients, carers, and health enthusiasts is celebrating our 30th anniversary in 2023.
  21. [21]
    Cochrane's sustainable path to open access
    Apr 8, 2024 · All Cochrane reviews are free to access after 12 months, all protocols and editorials will be open access in 2025. National provisions, paid ...
  22. [22]
    Cochrane Methods Report 2025
    Oct 22, 2025 · Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence, formed a new AI Methods Group in February 2025 to ...
  23. [23]
    Who we are | Cochrane
    ### Summary of Cochrane's Structure
  24. [24]
    How you can be a part of Cochrane
    Cochrane's 11,000 members and over 68,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, ...
  25. [25]
    https://www.cochranelibrary.com/about/cochrane-review-groups
  26. [26]
    Cochrane Review Groups
    A list of active Cochrane Review Groups and their Co-ordinating Editors can be viewed at Cochrane.org | Review Groups.
  27. [27]
    Our groups - Cochrane
    We have official Geographic Groups in more than 50 countries. These groups represent Cochrane in that country: they promote and support the use of Cochrane ...Heart, Stroke and Circulation · Health Equity · Acute and Emergency Care
  28. [28]
    [PDF] Guide to the contents of a Cochrane Methodology protocol and review
    Cochrane Methodology reviews are published in the Cochrane Database of Systematic Review (CDSR) alongside Cochrane reviews of the effects of healthcare ...Missing: workflow | Show results with:workflow
  29. [29]
    Guidance to best tools and practices for systematic reviews - PMC
    This guideline was designed to help authors prepare a complete and transparent report of their systematic review. In addition, adherence to PRISMA is often used ...
  30. [30]
    Cochrane Database of Systematic Reviews: all issues | Cochrane ...
    Cochrane Database of Systematic reviews: all issues · 2025, Issue 2 · Reviews · Protocols.
  31. [31]
    [PDF] Guidance for the production and publication of Cochrane living ...
    The purpose of the guidance is to outline the methods, production and publication processes for living systematic reviews of interventions published in the ...
  32. [32]
    How to work on a Cochrane review - Covidence Knowledge Base
    Covidence is recognised by Cochrane as the primary screening and data extraction tool for Cochrane authors conducting standard intervention reviews.
  33. [33]
    Artificial Intelligence and Automation in Evidence Synthesis: An ...
    Aug 28, 2025 · The majority (~89%, 2025 studies) were published in the Cochrane ... The development of open-source, interpretable AI tools could also ...
  34. [34]
    How is Cochrane advancing responsible AI for evidence synthesis?
    Jun 24, 2025 · In June 2025, RAISE released an updated three-paper collection: RAISE 1: Recommendations for practice across roles in the evidence synthesis ...Missing: access | Show results with:access
  35. [35]
    [PDF] Trustees' Report and Financial Statements - Cochrane
    Jul 22, 2025 · The Board usually reviews its performance annually at a face-to-face meeting when Trustees reflect on how well they are fulfilling their duties ...
  36. [36]
    Funding and support | Cochrane Emergency and Critical Care
    The individual entities of The Cochrane Collaboration are funded by a large variety of governmental, institutional and private funding sources, and are bound by ...Missing: history | Show results with:history
  37. [37]
    Cochrane Library - Department of Health, Disability and Ageing
    Oct 30, 2023 · The Cochrane Library is a collection of databases that contain high-quality, independent evidence to inform healthcare decision-making.<|separator|>
  38. [38]
    Paths to Full Open Access for Cochrane Reviews - Absolutely Maybe
    Mar 23, 2025 · Cochrane has another journal, Cochrane Evidence Synthesis and Methods, which is open access via charges to authors. Open access models for ...
  39. [39]
    Cochrane Database of Systematic Reviews: all issues
    Cochrane Library logo. Trusted evidence. Informed decisions. Better health ... Cochrane Database of Systematic reviews: all issues. Browse issues. 2025.
  40. [40]
    Chapter 14: Completing 'Summary of findings' tables and grading ...
    In the Cochrane Database of Systematic Reviews (CDSR), all 'Summary of findings' tables for a review appear at the beginning, before the Background section.
  41. [41]
    Chapter III: Reporting the review - Cochrane
    A Cochrane Plain language summary is a stand-alone summary of the systematic review. Like the Abstract, the Plain language summary may be read alone, and ...
  42. [42]
    Cochrane Database of Systematic Reviews (COCH) - Ovid
    Sep 9, 2025 · Cochrane Methodology Reviews are full-text systematic reviews of methodological studies. The reviews are both highly structured and systematic.
  43. [43]
    Cochrane reviews received more online attention than other ...
    Apr 19, 2025 · The final analysis included 11,913 Cochrane reviews and 173,915 other systematic reviews, with 6,031 published in historically leading medical ...<|separator|>
  44. [44]
    Checking reference lists to find additional studies for systematic ...
    Lessons for search strategies from a systematic review, in The Cochrane Library, of nutritional supplementation trials in patients after hip fracture. American ...
  45. [45]
    Cochrane Controlled Register of Trials (CENTRAL)
    CENTRAL is a rich database of bibliographic reports of randomized controlled trials. You can search CENTRAL for high-quality evidence from many trusted sources.
  46. [46]
    What's new | Cochrane Library
    We've redesigned key features to help you find, understand, and act on the evidence that matters most: Smarter ways to engage - clear, intuitive ways to ...
  47. [47]
    Chapter 4: Searching for and selecting studies - Cochrane
    This chapter outlines some general issues in searching for and selecting studies. It describes the main sources of potential studies; and discusses how to plan ...
  48. [48]
    About Cochrane Clinical Answers
    Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane review deemed most relevant to practicing healthcare ...
  49. [49]
    Cochrane Clinical Answers
    Each CCA contains a clinical question, a short answer, and data for the outcomes from the Cochrane review deemed most relevant to practising healthcare ...
  50. [50]
    23 Special Collections matching * in All Text - Cochrane Library
    Special Collections 23 · Clinical Answers 3575; More. Trials 2298327 · Editorials 157 · Special Collections 23 · Clinical Answers 3575. 23 Special Collections ...
  51. [51]
    Methodology Register | Cochrane Qualitative and Implementation
    The Cochrane Qualitative Evidence Synthesis (QES) Register is currently being migrated to a new home. Examples of any form of qualitative evidence synthesis.
  52. [52]
    CRD Database Info - Cochrane Library
    The Centre for Reviews and Dissemination is no longer adding records to the Health Technology Assessment (HTA) database. The International Network of Agencies ...
  53. [53]
    How to order | Cochrane Library
    If you are interested in funding public access for Cochrane Library in your country, reach out to libraryinfo@wiley.com to begin a conversation with our team.Missing: sources | Show results with:sources
  54. [54]
    Why we need access to the Cochrane library - University of Auckland
    Aug 22, 2025 · National subscriptions to the Cochrane Library are funded for Australia, Brazil, South Africa, Malaysia, Denmark, Finland, Ireland, Spain, ...
  55. [55]
    National License Access to The Cochrane Library for All Canadians
    Residents in a number of countries and regions can access The Cochrane Library for free through a 'provision' or national license. Largely funded by ...
  56. [56]
    Open Access | Cochrane Library
    Open access options for the Cochrane Database of Systematic Reviews. Authors can choose one of two options for publishing their Cochrane review.
  57. [57]
    Mobile App - Using Cochrane Library - LibGuides at Azusa Pacific ...
    Sep 9, 2025 · The Cochrane Library app is the perfect format for catching up on the latest evidence from the Cochrane Database of Systematic Reviews.
  58. [58]
    List of countries eligible for free one-click access to the Cochrane ...
    Apr 12, 2018 · Effective 7 February 2018, Azerbaijan, Belarus and Venezuela (Bolivarian Republic of) are now on the list of eligible countries.Missing: national licenses OECD
  59. [59]
    So what has the Cochrane Collaboration ever done for us? A report ...
    For users in countries classified by the World Bank as low- or middle-income the Cochrane Library is available through HINARI (the Health InterNetwork Access ...
  60. [60]
    About Cochrane Database of Systematic Reviews impact metrics
    Our publisher, Wiley, is a signatory to the San Francisco Declaration on Research Assessment (DORA), a commitment to providing a broad range of metrics. We ...<|control11|><|separator|>
  61. [61]
    Analysis of Cochrane systematic reviews: A comprehensive study of ...
    Dec 9, 2024 · There was a fluctuating pattern in publication and citation trends within Cochrane reviews, with a decline in both metrics since 2016.
  62. [62]
    [PDF] Learning from Cochrane's initial response to COVID-19 (External ...
    Usage growth rates returned to usual levels for most databases quickly. Figure 3: Trends in visits to the Cochrane Library databases. 1,800,000. 1,600,000.
  63. [63]
    Usage Statistics for Cochrane Clinical Answers
    Mar 2, 2020 · Usage statistics will be recorded as part of the Cochrane Yearly Report. The statistics will be broken down by Title homepage counts, full text CCA, abstract.Missing: downloads | Show results with:downloads
  64. [64]
    Cochrane: Statistics that save lives
    We examine the evidence behind questions that affect people's lives, empowering everyone to make better decisions.Our evidence · Cochrane membership · Our groups · Contact usMissing: Wiley 2003<|separator|>
  65. [65]
    The use of Cochrane Reviews in NICE clinical guidelines - PMC - NIH
    Aug 9, 2011 · There were 731 citations of Cochrane Reviews in the 106 guidelines, ranging from no citations to 44 citations, with a mean of 6.90 (standard deviation 9.23).
  66. [66]
    Tamiflu and Relenza: getting the full evidence picture - Cochrane
    May 8, 2014 · The latest updated Cochrane Review, published on 10 April 2014, is based on full internal reports of 20 Tamiflu and 26 Relenza trials.
  67. [67]
    Cochrane helps launch new WHO guidance on best practices for ...
    Oct 8, 2024 · “Disregarding existing evidence leads to redundant findings and fails to prioritize the gaps that we need to fill, missing the opportunity to ...Missing: inspiring | Show results with:inspiring
  68. [68]
    Lund leads the way using Cochrane tools to train doctors
    Apr 10, 2024 · Lund University in Sweden is using Cochrane training materials and tools to help medical students better understand and interpret health evidence.
  69. [69]
    GRADE - Cochrane
    GRADE is a systematic approach to rating the certainty of evidence in systematic reviews and other evidence syntheses.
  70. [70]
    Health Equity - Cochrane
    Our aim is to raise the profile of health equity within Cochrane review to help improve the evidence base about interventions that may reduce health inequities.
  71. [71]
    Lifecycles of Cochrane Systematic Reviews (2003–2024) - NIH
    Aug 17, 2025 · The relevance of Cochrane systematic reviews depends on timely completion and updates. This study aimed to empirically assess the lifecycles ...
  72. [72]
    Cochrane's COVID‐19 Living Systematic Reviews: A Mixed ...
    Mar 28, 2025 · We conducted a mixed-methods study to describe the characteristics of Cochrane's COVID-19 living reviews, determine the currency of the included evidence,
  73. [73]
    Cochrane's COVID‐19 Living Systematic Reviews - PubMed Central
    This study found that half of Cochrane's 25 COVID-19 living reviews were not updated by June 2023, and only one communicated new evidence after publication.Missing: criticism | Show results with:criticism
  74. [74]
    Around ten percent of most recent Cochrane reviews included ...
    We found that approximately 10% of recent Cochrane reviews on interventions included outcomes in their literature search strategies.
  75. [75]
    dealing with problematic studies in systematic reviews
    Jun 3, 2021 · The Cochrane policy for managing potentially problematic studies and accompanying implementation guidance set out how Cochrane Review authors ...
  76. [76]
    Exercise therapy for chronic fatigue syndrome - Larun, L - 2019
    Oct 2, 2019 · In 2018, following receipt of a formal complaint about the Cochrane Review, 'Exercise therapy for chronic fatigue syndrome', the then Editor ...Missing: resignation | Show results with:resignation
  77. [77]
    Evidence-based medicine group in turmoil after expulsion of co ...
    Evidence-based medicine group in turmoil after expulsion of co-founder · Cochrane collaboration dismisses industry scold Peter Gøtzsche on the eve of its annual ...
  78. [78]
    Why systematic reviewers should lead the charge for research integrity
    Jul 8, 2025 · Lisa Bero argues that systematic reviewers are uniquely positioned – and ethically obligated – to detect problematic studies and champion research integrity.
  79. [79]
    What is Cochrane doing to strengthen research integrity?
    Oct 29, 2025 · Cochrane is continuing to advance responsible AI for evidence synthesis, which recent developments in using AI to support review authors, as ...
  80. [80]
    Call to action: building a better future together, powered by evidence ...
    Sep 22, 2025 · This call to action invites governments, funders, evidence producers, intermediaries and citizens to shape that future together, replacing ...